Suppr超能文献

比较 5-甲基四唑基铱(III)和/或铑(III)配合物的键合和桥联异构中 2,2'-联吡啶和 2-(2'-吡啶基)苯基辅助配体的影响。

Comparison of ancillary ligand effects between 2,2'-bipyridine and 2-(2'-pyridyl)phenyl in the linkage and bridging isomerism of 5-methyltetrazolato iridium(III) and/or rhodium(III) complexes.

机构信息

Department of Chemistry, Faculty of Science, Okayama University, Tsushima-naka 3-1-1, Okayama 700-8530, Japan.

出版信息

Dalton Trans. 2013 Oct 28;42(40):14556-67. doi: 10.1039/c3dt51667a.

Abstract

Several new iridium(III) and rhodium(III) complexes bearing 5-methyltetrazolate (MeCN4(-)) have been prepared, and their structures in the crystals and in solution have been determined by X-ray analysis and by NMR spectroscopy, respectively. In the crystals of the mononuclear complexes, κN(2)-coordination of MeCN4(-) was observed when the ancillary ligand was 2,2'-bipyridine (bpy): [CpM(bpy)(MeCN4-κN(2))]PF6 (Cp = η(5)-C5Me5; M = Ir: 1 and Rh: 2), while the corresponding complexes with 2-(2'-pyridyl)phenyl (ppy(-)) were confirmed to have the κN(1)-coordination of MeCN4(-): [CpM(ppy)(MeCN4-κN(1))] (M = Ir: 3 and Rh: 4). In solution, the Ir(III) complexes (1 and 3) were robust enough to maintain their molecular structures, but the Rh(III) complexes (2 and 4) existed as an equilibrium mixture of the κN(1)- and κN(2)-isomers. In addition to the Ir(III)-Ir(III) and Rh(III)-Rh(III) homodinuclear complexes bridged by MeCN4(-) (5-8), the corresponding heterodinuclear Ir(III)-Rh(III) complexes (9-12) were prepared using the mononuclear Ir(III) complexes (1 and 3) as precursors. The molecular structures of these dinuclear complexes were also characterised. Interestingly, both of the heterodinuclear complexes comprised of CpM(bpy)(2+) and CpM'(ppy)(+) fragments, CpM(bpy)(μ-MeCN4)M'(ppy)Cp2 (M = Ir, M' = Rh: 10 and M = Rh, M' = Ir: 11), exhibited selective crystallisation of a specific μ-κN(1)(M'-ppy):κN(3)(M-bpy) isomer. In solution, the dinuclear complexes with a Rh-N(MeCN4) bond and more than one positive charge (6 and 9-11) showed a dissociation equilibrium, while monocationic MeCN4-bridged complexes (7, 8 and 12) were inactive for dissociation. Furthermore, the heterodinuclear complexes of 9-12, as well as the Rh(III)-Rh(III) complex of 8, exhibited a bridging isomerisation, which would proceed via a η(2):η(2)-intermediate without dissociation of CpM(bpy or ppy) fragments.

摘要

几种新的铱(III)和铑(III)配合物,带有 5-甲基四唑(MeCN4(-)),已被制备,并通过 X 射线分析和 NMR 光谱分别确定了其晶体和溶液中的结构。在单核配合物的晶体中,当辅助配体为 2,2'-联吡啶(bpy)时,观察到 MeCN4(-)的κN(2)配位:[CpM(bpy)(MeCN4-κN(2))]PF6(Cp=η(5)-C5Me5;M=Ir:1 和 Rh:2),而具有 2-(2'-吡啶基)苯基(ppy(-))的相应配合物被证实具有 MeCN4(-)的κN(1)配位:[CpM(ppy)(MeCN4-κN(1))](M=Ir:3 和 Rh:4)。在溶液中,Ir(III)配合物(1 和 3)足够稳定,可以保持其分子结构,但 Rh(III)配合物(2 和 4)存在κN(1)-和κN(2)-异构体的平衡混合物。除了由 MeCN4(-)(5-8)桥接的 Ir(III)-Ir(III)和 Rh(III)-Rh(III)同核双核配合物外,还使用单核 Ir(III)配合物(1 和 3)作为前体制备了相应的异核 Ir(III)-Rh(III)配合物(9-12)。这些双核配合物的分子结构也得到了表征。有趣的是,两个异核双核配合物都包含 CpM(bpy)(2+)和 CpM'(ppy)(+)片段,[CpM(bpy)(μ-MeCN4)M'(ppy)Cp*](PF6)2(M=Ir,M'=Rh:10 和 M=Rh,M'=Ir:11),表现出特定的μ-κN(1)(M'-ppy):κN(3)(M-bpy)异构体的选择性结晶。在溶液中,具有 Rh-N(MeCN4)键和多个正电荷的双核配合物(6 和 9-11)显示出离解平衡,而单核 MeCN4 桥联配合物(7、8 和 12)对于离解是无活性的。此外,9-12 的异核双核配合物以及 8 的 Rh(III)-Rh(III)配合物,表现出桥联异构化,该异构化将通过η(2):η(2)-中间体进行,而不会使 Cp*M(bpy 或 ppy)片段离解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验